Trial Profile
Shifting the Paradigm of Gout: An Assessment of Chronic Synovial-Based Inflammation and Its Role With Serum Urate Levels.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Colchicine (Primary) ; Febuxostat (Primary)
- Indications Gout
- Focus Therapeutic Use
- 17 Jul 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 11 Dec 2013 Planned end date changed from 1 Mar 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov.
- 16 Jul 2012 Planned end date changed from 1 May 2011 to 1 Mar 2013 as reported by ClinicalTrials.gov.